Craneware Plc

Craneware Plc

CRW · LSE · Healthcare / Health Information Services

1,062.00GBX+2.00 (+0.19%)

Price History

Full chart

Market Stats

Previous Close1,060.00
Open1,064.00
Day Range1,005.00 – 1,064.00
52-Week Range988.00 – 2,403.34
Volume88.46K
Market Cap348.53M
P/E (TTM)24.24
Forward P/E16.53
EPS0.42
Dividend Yield3.00%
Beta-0.15
50-Day Avg1,250.64
200-Day Avg1,436.07

About

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. It provides solutions, such as Trisus Pricing Analyzer and Transparency, a solution that optimizes and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity requirements; Trisus Claims Informatics, a retrospective charge capture analytical application; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit solution for government and commercial payors. The company also offers Trisus Decision Support; Trisus Labor Productivity, which enables healthcare providers to manage, analyze, and plan the deployment of workforce; Trisus Medication Analytic solutions that prioritize, diagnose, and resolve issues in medication systems; and Trisus Supplies Assistant solutions which supplies charged data. In addition, it provides Sentrex, a SaaS-based solution that helps covered entities expand medication access; Sentinel, that tracks all drug activity; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, the company offers professional, pharmacy professional, and appeal services. Additionally, the company provides The Academy, an interactive learning center for user training; Trisus Pricing Integrity Suite; Trisus Business of Pharmacy Suite, which offers solutions centered on each link in the medication revenue cycle; Trisus Value-based Margin and Productivity Suite; and Trisus Data Integrity Suite, which creates a proactive workflow that aligns data between operating units, the supply chain and revenue cycle. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Keith Neilson
  • Employees765
  • Headquarters1 Tanfield, Edinburgh, United Kingdom, EH3 5DA, UK
  • Websitehttps://www.thecranewaregroup.com

Leadership

  • Mr. Keith NeilsonCo-Founder, CEO & Executive Director · b. 1969
  • Mr. Craig Thomas Preston ACACFO, Company Secretary & Executive Director · b. 1970
  • Ms. Isabel UrquhartChief People Officer & Director · b. 1968
  • Mr. Abhilesh GandhiGroup Chief Technology Officer
  • Mr. Eric CarterChief Legal Officer
  • Ms. Lidia A. Rodriguez-HuppChief Customer Officer
  • Ms. Tara HanuscakChief Transformation Officer
  • Mr. Ian ArmstrongChief Growth Officer
  • Jill GoldsmithCompany Secretary

Financials

Income Statement

Currency: USD2005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue5.83M13.18M15.11M18.68M22.99M28.40M38.12M41.07M41.45M42.57M44.82M49.85M57.80M67.07M71.40M71.49M75.58M165.54M174.02M189.27M205.66M206.47M
Growth (%)-+125.89%+14.66%+23.59%+23.12%+23.50%+34.25%+7.72%+0.94%+2.71%+5.27%+11.22%+15.95%+16.04%+6.46%+0.13%+5.72%+119.04%+5.12%+8.76%+8.66%+0.40%
Cost of Revenue629.00K1.12M808.82K954.00K1.38M2.55M4.70M1.56M2.07M1.94M2.42M3.01M3.58M3.41M4.39M4.52M5.37M23.18M25.58M27.07M26.38M67.72M
Gross Profit5.21M12.06M14.30M17.72M21.61M25.84M33.43M39.51M39.38M40.63M42.40M46.84M54.21M63.66M67.01M66.97M70.20M142.37M148.44M162.20M179.27M138.75M
Gross Margin89.22%91.49%94.65%94.89%93.99%91.01%87.68%96.21%95.00%95.44%94.60%93.96%93.80%94.92%93.85%93.68%92.89%86.00%85.30%85.70%87.17%67.20%
Operating Expense3.71M8.98M12.91M14.14M16.26M18.78M24.87M28.42M28.88M29.41M29.98M33.02M37.59M44.97M49.00M47.77M56.97M124.23M129.21M142.46M154.02M111.03M
Operating Income1.50M3.08M1.40M3.58M5.35M7.06M8.55M11.10M10.50M11.22M12.41M13.81M16.63M18.69M18.00M19.21M13.24M18.13M19.23M19.73M25.25M27.72M
Operating Margin25.63%23.34%9.24%19.17%23.27%24.87%22.44%27.02%25.33%26.36%27.69%27.71%28.77%27.87%25.22%26.86%17.52%10.95%11.05%10.43%12.28%13.43%
EBITDA1.64M3.43M1.54M3.93M5.78M7.49M9.98M13.79M11.55M12.18M13.37M15.18M17.31M19.50M21.86M23.87M18.48M47.54M51.60M54.26M38.80M62.26M
EBITDA Margin28.15%26.01%10.21%21.04%25.14%26.38%26.18%33.59%27.87%28.60%29.82%30.46%29.94%29.08%30.61%33.39%24.46%28.72%29.65%28.67%18.87%30.15%
Net Income1.03M2.14M1.22M3.29M4.45M5.53M6.01M8.89M8.30M8.61M9.39M10.57M13.53M15.80M14.98M16.84M12.90M9.41M9.23M11.70M19.66M19.78M
Net Income Margin17.60%16.27%8.05%17.61%19.35%19.46%15.78%21.65%20.01%20.22%20.95%21.22%23.40%23.55%20.99%23.55%17.08%5.68%5.31%6.18%9.56%9.58%
R&D--2.17M2.62M2.96M3.79M5.02M6.84M6.93M6.98M6.99M7.67M9.11M13.17M10.40M12.27M14.55M37.58M6.76M8.06M10.39M-
R&D as % of Total Revenue--14.38%14.04%12.87%13.33%13.18%16.67%16.72%16.39%15.59%15.38%15.76%19.64%14.57%17.16%19.25%22.70%3.88%4.26%5.05%-
Interest Expense15.00K234.57K507.77K559.41K469.02K210.95K847.70K2.04M1.00K20.00K292.00K965.00K384.00K340.00K2.09M94.00K76.00K5.03M6.36M5.13M1.27M1.93M
Interest Expense % of Total Revenue0.26%1.78%3.36%3.00%2.04%0.74%2.22%4.96%0.00%0.05%0.65%1.94%0.66%0.51%2.93%0.13%0.10%3.04%3.65%2.71%0.62%0.94%

Balance Sheet

Currency: USD2005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets5.88M13.55M15.49M28.16M33.65M41.31M57.40M60.86M64.38M72.86M78.22M93.78M97.15M98.93M106.30M115.76M311.60M568.79M576.98M543.65M551.06M524.46M
Total Liabilities6.49M12.20M11.74M12.06M14.97M19.26M25.00M23.42M23.05M27.94M30.59M40.97M37.80M47.29M46.47M47.36M51.32M235.77M249.13M215.06M213.50M204.14M
Total Equity-606.00K1.34M3.75M16.10M18.68M22.05M32.41M37.44M41.32M44.92M47.63M52.81M59.35M51.65M59.84M68.39M260.28M333.02M327.84M328.59M337.56M320.31M
Cash3.37M10.17M9.66M21.11M26.17M29.44M24.18M28.79M30.28M32.61M41.83M48.81M53.17M52.83M47.61M47.85M235.62M47.16M78.54M34.59M55.92M55.10M
Total Debt---------------2.96M2.20M115.52M86.69M40.15M31.65M46.77M
Net Debt-3.37M-10.17M-9.66M-21.11M-26.17M-29.44M-24.18M-28.79M-30.28M-32.61M-41.83M-48.81M-53.17M-52.83M-47.61M-44.89M-234.47M65.93M8.15M5.56M-24.27M-8.33M

Cash Flow

Currency: USD2005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow1.83M4.00M987.44K3.49M7.18M6.72M8.49M9.29M6.62M8.11M19.58M15.42M17.85M29.99M13.46M20.67M23.54M26.96M98.75M41.86M59.90M42.74M
Investing Cash Flow-199.00K125.60K-491.71K18.00K-202.00K-453.00K-10.71M-750.00K-526.00K-414.00K-1.44M-2.58M-4.58M-4.69M-10.43M-9.71M-10.32M-307.32M-15.34M-15.81M-13.98M-17.40M
Financing Cash Flow-2.18M--999.49K7.94M-1.92M-2.99M-3.05M-3.92M-4.60M-5.36M-8.93M-5.86M-8.91M-25.63M-8.25M-10.72M174.55M91.90M-53.28M-70.00M-24.58M-26.44M
Capital Expenditure215.00K110.82K937.27K589.00K722.00K648.00K2.04M857.00K526.00K414.00K1.19M2.58M4.58M4.69M10.43M9.71M10.33M14.03M15.55M16.96M491.00K474.18K
Free Cash Flow1.61M3.89M50.17K2.90M6.45M6.07M6.46M8.43M6.09M7.70M18.39M12.84M13.27M25.30M3.03M10.96M13.21M12.93M83.20M24.91M59.41M42.26M
Dividends Paid--999.49K-1.92M2.99M3.06M4.09M4.69M5.36M5.39M5.95M6.36M7.82M8.50M9.08M9.70M12.98M12.12M12.80M13.27M15.78M
FCF to OCF88.23%97.23%5.08%83.13%89.94%90.35%76.02%90.77%92.05%94.89%93.93%83.24%74.35%84.35%22.50%53.03%56.13%47.96%84.25%59.49%99.18%98.89%
Dividend Paid to FCF--1992.00%-29.70%49.29%47.44%48.56%77.05%69.64%29.29%46.37%47.89%30.90%280.52%82.81%73.42%100.35%14.57%51.39%22.33%37.34%

Earnings

Report DateMar 8, 2016Sep 6, 2016Mar 6, 2017Sep 4, 2017Mar 6, 2018Sep 5, 2018Mar 5, 2019Sep 3, 2019Mar 1, 2021Sep 21, 2021Mar 14, 2022Sep 20, 2022Mar 6, 2023Mar 11, 2025Sep 1, 2025Oct 22, 2025
EPS Estimate0.000.230.150.000.000.260.000.000.000.000.000.000.000.00-0.00
EPS Actual0.170.220.210.290.240.000.000.000.000.000.000.000.000.210.350.35
Surprise--4.35%40.00%---100.00%----------
Timing-----------Pre-marketPre-market-Pre-market-

Key Statistics & Ratios

Market Cap348.53M
Enterprise Value353.96M
Trailing P/E24.24
Forward P/E16.53
PEG Ratio0.00
Price / Sales1.69
Price / Book1.51
EPS0.42
Book Value7.22
Revenue (TTM)205.96M
Gross Profit (TTM)172.85M
EBITDA39.15M
Profit Margin9.58%
Operating Margin13.19%
Return on Equity6.01%
Return on Assets3.09%
Shares Outstanding34.24M
Shares Float23.89M
Beta-0.15
Dividend Yield3.00%
Dividend Rate0.32
Payout Ratio95.71%

Dividends

20261×
0.15Mar 19, 2026
20252×
0.18Nov 27, 20250.14Mar 20, 2025
20242×
0.16Nov 28, 20240.13Mar 21, 2024
20232×
0.16Nov 23, 20230.13Mar 23, 2023
20222×
0.15Nov 24, 20220.13Mar 24, 2022
20212×
0.15Nov 25, 20210.12Mar 18, 2021
20202×
0.15Nov 19, 20200.12Mar 19, 2020
20192×
0.15Nov 28, 20190.11Mar 14, 2019
20182×
0.14Nov 8, 20180.10Mar 29, 2018
20172×
0.11Nov 9, 20170.09Mar 30, 2017
20162×
0.09Nov 10, 20160.07Mar 17, 2016
20152×
0.08Nov 19, 20150.06Mar 26, 2015
20141×
0.07Nov 13, 2014